Advertisement
Case Report| Volume 15, ISSUE 6, e1123-e1126, December 2017

Chemosensitivity of Immature Teratoma in a Man

      There is a paucity of clinical data and understanding on immature teratoma in men.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ulbright T.M.
        Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
        Mod Pathol. 2005; 18: S61-S79
        • Norris H.J.
        • Zirkin H.J.
        • Benson W.L.
        Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases.
        Cancer. 1976; 37: 2359-2372
        • Colombo N.
        • Peiretti M.
        • Garbi A.
        • et al.
        Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
        Ann Oncol. 2012; 23: vii20-vii26
        • Alwazzan A.B.
        • Popowich S.
        • Dean E.
        • et al.
        Pure immature teratoma of the ovary in adults: thirty-year experience of a single tertiary care center.
        Int J Gynecol Cancer. 2015; 25: 1616-1622
        • Bonazzi C.
        • Peccatori F.
        • Colombo N.
        • et al.
        Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients.
        Obstet Gynecol. 1994; 84: 598-604
        • Williams S.D.
        • Blessing J.A.
        • Moore D.H.
        • et al.
        Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ-cell tumors. A trial of the Gynecologic Oncology Group.
        Ann Intern Med. 1989; 111: 22-27
        • Carver B.S.
        • Shayegan B.
        • Serio A.
        • et al.
        Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
        J Clin Oncol. 2007; 25: 1033-1037
        • Wetherell D.
        • Weerakoon M.
        • Williams D.
        • et al.
        Mature and immature teratoma: a review of pathological characteristics and treatment options.
        Med Surg Urol. 2014; 3: 124
        • Lee A.C.
        • Chan G.C.
        • Fung C.F.
        • et al.
        Paradoxical response of a pineal immature teratoma to combination chemotherapy.
        Med Pediatr Oncol. 1995; 24: 53-57
        • Loehrer Sr., P.J.
        • Hui S.
        • Clark S.
        • et al.
        Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
        J Urol. 1986; 135: 1183-1189
        • Michael H.
        • Hull M.T.
        • Ulbright T.M.
        • et al.
        Primitive neuroectodermal tumors arising in testicular germ cell neoplasms.
        Am J Surg Pathol. 1997; 21: 896-904
        • Dunne R.F.
        • Sahasrabudhe D.M.
        • Messing E.M.
        • et al.
        A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy.
        Rare Tumors. 2014; 6: 5268
        • Ganjoo K.N.
        • Foster R.S.
        • Michael H.
        • et al.
        Germ cell tumor associated primitive neuroectodermal tumors.
        J Urol. 2001; 165: 1514-1516
        • Al-Hader A.A.
        • Jain A.
        • Al-Nasrallah N.
        • et al.
        Metastatic malignant transformation of teratoma to primitive neuroectodermal tumor (PNET): results with PNET-based chemotherapy.
        Am J Clin Oncol. 2015; 38: 364-366
        • Ehrlich Y.
        • Beck S.D.
        • Ulbright T.M.
        • et al.
        Outcome analysis of patients with transformed teratoma to primitive neuroectodermal tumor.
        Ann Oncol. 2010; 21: 1846-1850